The implication of PAF in HIV-infection is further supported by the beneficial effect of PAF antagonists administration in animal models for HIV-1 encephalitis [31,32] as well by the improvement of neuropsychological test scores in HIV-patients under lexipafant, the first PAF antagonist used in HIV-associated cognitive impairment [33]. This evidence concerns the gene PCLAF and HIV infectious disease.